agilon health Sets Date to Report Third Quarter 2026 Financial Results
Business Wire (Mon, 5-Oct 4:05 PM ET)
Bernstein Sticks to Its Buy Rating for Agilon Health (AGL)
TipRanks (Mon, 5-Oct 7:46 AM ET)
agilon health and The Jackson Clinic Advance Their Partnership Through Senior Health Connect ACO
Business Wire (Wed, 30-Sep 9:00 AM ET)
Market Chameleon (Thu, 24-Sep 7:51 AM ET)
agilon health and Springfield Clinic Broaden Partnership Through Senior Health Connect ACO
Business Wire (Wed, 23-Sep 9:00 AM ET)
agilon health and Family Practice Center Expand Relationship Through Senior Health Connect ACO
Business Wire (Thu, 10-Sep 9:00 AM ET)
Business Wire (Thu, 27-Aug 4:05 PM ET)
agilon health to Participate in Upcoming Conferences
Business Wire (Thu, 20-Aug 4:05 PM ET)
agilon health Reports Second Quarter 2026 Results
Business Wire (Wed, 5-Aug 4:05 PM ET)
Did agilon health, inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Wed, 29-Jul 9:14 AM ET)
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
Agilon Health trades on the NYSE stock market under the symbol AGL.
As of October 8, 2026, AGL stock price declined to $83.93 with 81,988 million shares trading.
AGL has a beta of 5.55, meaning it tends to be more sensitive to market movements. AGL has a correlation of 0.20 to the broad based SPY ETF.
AGL has a market cap of $1.40 billion. This is considered a Small Cap stock.
Last quarter Agilon Health reported $1 billion in Revenue and $1.04 earnings per share. This beat revenue expectation by $45 million and exceeded earnings estimates by $.90.
In the last 3 years, AGL traded as high as $509.25 and as low as $7.48.
The top ETF exchange traded funds that AGL belongs to (by Net Assets): VTI, IWM, FNDA, VXF, IWO.
AGL has outperformed the market in the last year with a return of +216.7%, while the SPY ETF gained +16.6%. However, in the most recent history, AGL shares have underperformed the stock market with its stock returning -21.9% in the last 3 month period and -0.7% for the last 2 week period, while SPY has returned +3.6% and +0.7%, respectively.
AGL support price is $81.95 and resistance is $89.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGL shares will trade within this expected range on the day.